Cassava Sciences' Simufilam 100 Mg For Mild-To-Moderate Alzheimer's Disease (RETHINK-ALZ) Posted On ClinicalTrials Website On November 15, 2024
Cassava Sciences' Simufilam 100 Mg For Mild-To-Moderate Alzheimer's Disease (RETHINK-ALZ) Posted On ClinicalTrials Website On November 15, 2024
2024年11月15日,cassava sciences的Simufilam 100毫克用于轻至中度阿尔茨海默病(RETHINk-ALZ)在ClinicalTrials网站上发布。
Cassava Sciences' Simufilam 100 Mg For Mild-To-Moderate Alzheimer's Disease (RETHINK-ALZ) Posted On ClinicalTrials Website On November 15, 2024
2024年11月15日,cassava sciences的Simufilam 100毫克用于轻至中度阿尔茨海默病(RETHINk-ALZ)已经发布在临床试验网站上。